ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,701.70
0.96%
S&P ASX All Technology
3,075.00
0.84%
Brent Oil
81.295
0.00%
US Dollar vs AUD
1.49858
-0.15%
Bitcoin
67,746.03
0.39%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Seelos Therapeutics Inc (SEEL)

  7. Seelos Therapeutics Inc (SEEL) News

SEEL

Seelos Therapeutics (SEEL)

Seelos Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SEEL
DateTimeSourceHeadlineSymbolCompany
01/06/202406:30Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:SEELSeelos Therapeutics Inc
22/05/202406:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEELSeelos Therapeutics Inc
21/05/202406:16Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SEELSeelos Therapeutics Inc
16/05/202423:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEELSeelos Therapeutics Inc
15/05/202401:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEELSeelos Therapeutics Inc
14/05/202422:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SEELSeelos Therapeutics Inc
07/03/202409:32Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:SEELSeelos Therapeutics Inc
07/03/202408:50Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:SEELSeelos Therapeutics Inc
02/03/202409:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SEELSeelos Therapeutics Inc
15/02/202408:50Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:SEELSeelos Therapeutics Inc
07/02/202409:26Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SEELSeelos Therapeutics Inc
02/02/202422:04Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:SEELSeelos Therapeutics Inc
31/01/202408:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEELSeelos Therapeutics Inc
30/01/202422:05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SEELSeelos Therapeutics Inc
23/01/202400:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEELSeelos Therapeutics Inc
18/01/202413:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SEELSeelos Therapeutics Inc
18/01/202413:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SEELSeelos Therapeutics Inc
11/01/202408:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEELSeelos Therapeutics Inc
09/01/202413:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SEELSeelos Therapeutics Inc
09/01/202413:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SEELSeelos Therapeutics Inc
09/01/202413:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SEELSeelos Therapeutics Inc
09/01/202413:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SEELSeelos Therapeutics Inc
03/01/202400:10Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SEELSeelos Therapeutics Inc
28/12/202316:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SEELSeelos Therapeutics Inc
23/12/202308:01Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SEELSeelos Therapeutics Inc
23/12/202300:10Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SEELSeelos Therapeutics Inc
21/12/202308:59Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SEELSeelos Therapeutics Inc
21/12/202308:54Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SEELSeelos Therapeutics Inc
19/12/202308:54Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:SEELSeelos Therapeutics Inc
16/12/202308:06Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SEELSeelos Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SEEL

Your Recent History

COIN
BHDDEUR
TSXV
GDG
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved